Skip to content
Clinical Trials – home

Vulvovaginal dryness Diagnostics

1 / 1 trials open to patients1 country

In short

Vulvovaginal dryness is a common condition that affects women at any stage of life, causing discomfort and pain in intimate areas. While the problem is especially frequent during and after menopause, it can also occur due to hormonal changes, medications, or other health factors. Diagnosing this condition involves a careful review of symptoms, medical history, and simple physical examinations to identify the underlying cause and guide effective treatment.

Key points

  • Vaginal dryness affects about 17% of women ages 18-50 and over 50% after menopause, yet most never seek diagnosis due to embarrassment.
  • Diagnosis usually begins with a simple conversation about your symptoms and medical history, making it less intimidating than many women expect.
  • A pelvic examination allows healthcare providers to visually confirm vaginal dryness by observing thin, pale, or red vaginal tissues.
  • The vaginal pH test is a quick, simple procedure that provides immediate evidence of hormonal changes affecting vaginal health.
  • Blood tests measuring hormone levels aren't always necessary but can help confirm whether menopause or other hormonal issues are causing symptoms.
  • Clinical trials for vaginal dryness treatments typically require documented symptoms, pelvic examination findings, and sometimes hormone level testing for participant qualification.
  • Untreated vaginal dryness can lead to complications including recurrent infections, painful tears in vaginal tissue, and increased urinary tract infections.
  • With proper diagnosis and treatment, the prognosis for vaginal dryness is excellent—most women experience significant symptom relief and improved quality of life.

Introduction: Who Should Undergo Diagnostics

Vaginal dryness is more than just a minor irritation. It can significantly affect your quality of life, making everyday activities like sitting, walking, or exercising uncomfortable. The condition becomes especially noticeable during sexual activity, where it can cause pain, bleeding, and emotional distress. Around 17% of women between ages 18 and 50 experience vaginal dryness during sex, and this number rises to over 50% after menopause. Despite how common it is, many women feel embarrassed to discuss their symptoms with healthcare providers. This reluctance means that up to 75% of cases go undiagnosed, leaving women suffering in silence.

You should consider seeking diagnostic evaluation if you experience persistent dryness, burning, or itching in the vaginal area. Other signs that warrant a visit to your healthcare provider include pain or discomfort during sex, unusual vaginal discharge, spotting or bleeding after intercourse, and frequent urinary tract infections. If you find yourself needing to urinate more often than usual or experience painful urination, these could also be related to vaginal dryness. It's especially important to seek medical attention if symptoms have lasted for several weeks and home remedies haven't helped, or if vaginal dryness is affecting your daily life and intimate relationships.

Women going through certain life stages or medical treatments should be especially attentive to symptoms of vaginal dryness. This includes those approaching or experiencing menopause, new mothers who are breastfeeding, women taking hormonal birth control or certain medications like antidepressants or antihistamines, and those undergoing cancer treatment such as chemotherapy or radiation. Women with autoimmune conditions like Sjögren's syndrome (a disorder that causes dryness throughout the body) or diabetes should also be vigilant about vaginal health.

Diagnostic Methods

Diagnosing vulvovaginal dryness begins with a conversation between you and your healthcare provider. This discussion forms the foundation of understanding your condition. Your provider will ask detailed questions about your symptoms: when they started, how severe they are, what makes them better or worse, and how they affect your daily activities and intimate life. They will also inquire about your menstrual cycle, pregnancy history, medications you're currently taking, and any recent changes in your health or lifestyle.

This medical history review helps your healthcare provider understand the bigger picture. For example, if your symptoms began shortly after starting a new medication or after giving birth, this timing provides important clues about the cause. Your provider will also want to know whether you use any scented soaps, douches, or feminine hygiene products, as these can irritate vaginal tissues and worsen dryness. Being open and honest during this conversation is crucial, even though it may feel uncomfortable. Remember that healthcare providers discuss these issues regularly and are there to help, not to judge.

Physical Examination

After the conversation, your healthcare provider will typically perform a pelvic examination. During this exam, you'll lie on an examination table with your feet in supports while your provider visually inspects your external genitals (the vulva) and the opening of your vagina. They will look for signs of thinning tissues, redness, irritation, or inflammation. The lining of your vagina should normally appear thick, moist, and healthy. When vaginal dryness is present, the tissues often look thin, pale, or red instead.

Your provider may also gently insert a gloved finger into your vagina to feel the walls and assess their thickness, moisture level, and elasticity. This is called a digital examination. They might also use a speculum—a device that gently holds the vaginal walls open—to get a better view inside. This allows them to see the condition of the vaginal lining more clearly and check for any unusual discharge, sores, or other abnormalities. While pelvic exams can feel awkward, they're usually quick and shouldn't be painful, though they may cause some discomfort if you're experiencing significant dryness.

Laboratory Tests

In some cases, your healthcare provider may collect samples during the pelvic exam for laboratory testing. These tests help rule out other conditions that can cause similar symptoms or occur alongside vaginal dryness. One common test involves taking a sample of vaginal fluids to check for infections like yeast infections, bacterial vaginosis, or other types of vaginitis (inflammation of the vagina).

Your provider might also perform an acid balance test (also called a pH test). This involves either taking a sample of vaginal fluid or placing a special indicator strip inside your vagina to measure its acidity level. A healthy vagina typically has a slightly acidic environment. When estrogen levels drop, the vaginal pH can become less acidic, which may contribute to dryness and increase the risk of infections.

If there's a concern about your hormone levels, your doctor may order blood tests to measure estrogen and other hormones. This is particularly helpful if the cause of your vaginal dryness isn't immediately clear or if you're experiencing other symptoms that suggest hormonal imbalance. Blood tests can show whether you're entering menopause, experiencing premature ovarian failure, or have other hormonal issues.

When urinary symptoms accompany vaginal dryness—such as frequent urination, painful urination, or recurring urinary tract infections—your provider may request a urine test (urinalysis). This simple test involves providing a urine sample that's analyzed in a laboratory. It can detect infections, blood in the urine, or other abnormalities that might be related to your symptoms.

Additional Diagnostic Procedures

In most cases, vaginal dryness can be diagnosed through medical history and a basic pelvic examination. However, if your healthcare provider suspects other underlying conditions or if initial treatments don't provide relief, additional procedures might be recommended. One such procedure is colposcopy, where a special magnifying instrument is used to examine the vagina and cervix more closely. This allows your provider to see details that aren't visible during a regular pelvic exam.

In rare cases where more information is needed, your provider might perform a cervical or vaginal cell collection (similar to a Pap test). Cells from the vaginal wall or cervix are gently scraped or brushed off and sent to a laboratory for examination under a microscope. This can help identify cellular changes that might indicate other conditions affecting vaginal health.

It's important to note that tests are not always necessary for diagnosing vaginal dryness. If your symptoms are typical and your medical history clearly points to a likely cause—such as menopause or starting a new medication—your provider may proceed with treatment recommendations without extensive testing.

Diagnostics for Clinical Trial Qualification

Clinical trials studying treatments for vulvovaginal dryness or conditions related to menopause typically have specific requirements for participants. These requirements help researchers ensure that the study includes the right patients and that the results are reliable and meaningful. Understanding these diagnostic criteria can be helpful if you're considering participating in research.

Most clinical trials for vaginal dryness treatments require confirmation of the diagnosis through standard methods. This usually includes a documented medical history showing symptoms consistent with vaginal dryness or genitourinary syndrome of menopause (GSM)—a term that encompasses both vaginal and urinary symptoms related to menopause. Researchers need to verify that participants truly have the condition being studied.

A pelvic examination is typically required as part of the screening process for clinical trials. During this exam, study physicians assess the physical signs of vaginal atrophy or dryness, such as thin vaginal tissues, paleness or redness of the vaginal lining, reduced moisture, and decreased elasticity. These objective findings help establish that a participant meets the criteria for enrollment.

Many trials also require documentation of hormone levels, particularly estrogen. Blood tests measuring estrogen can confirm that participants are indeed experiencing low estrogen levels typical of menopause or other hormonal conditions. Some studies may also test levels of other hormones like follicle-stimulating hormone (FSH), which rises during menopause, to verify menopausal status.

The vaginal pH test is another common requirement in clinical trials studying vaginal dryness. Researchers often need to document that participants have an elevated vaginal pH (less acidic environment), which is characteristic of vaginal atrophy. A normal premenopausal vaginal pH is typically between 3.8 and 4.5, while postmenopausal women with vaginal atrophy often have a pH above 5.

Clinical trials may also require participants to complete standardized questionnaires or assessment tools that measure the severity of their symptoms. These might include questions about how often you experience dryness, how much it bothers you, how it affects sexual activity, and its impact on your daily quality of life. These assessments help researchers understand the baseline condition of participants and measure whether treatments are effective.

Some studies exclude certain participants to ensure safety or avoid factors that might confuse the results. For example, trials testing hormone-based treatments often require that participants don't have conditions that make hormone therapy risky, such as certain types of cancer, blood clotting disorders, or unexplained vaginal bleeding. Researchers may also exclude women who are pregnant, breastfeeding, or using certain medications that could interfere with the treatment being studied.

Prognosis and Survival Rate

Prognosis

The outlook for women with vulvovaginal dryness is generally very positive when appropriate treatment is received. Proper treatment can ease symptoms in most cases, allowing women to return to comfortable daily activities and satisfying intimate relationships. The condition itself is not life-threatening and does not progress to more serious diseases. However, without treatment, vaginal dryness can lead to several complications that affect quality of life and health.

Untreated vaginal dryness can make you more susceptible to yeast infections and bacterial infections of the vagina. The thin, dry vaginal tissues are more vulnerable to irritation and infection. The condition can also cause small tears or cracks in the vaginal walls, particularly during sexual activity, which can be painful and may bleed. These openings in the tissue can further increase infection risk.

Another potential complication is an increased risk of urinary tract infections. The same hormonal changes that cause vaginal dryness also affect the urinary tract, making infections more common. Some women experience recurring UTIs as a result of untreated vaginal atrophy.

Beyond physical complications, untreated vaginal dryness can significantly impact emotional well-being and intimate relationships. Pain during sexual intercourse may lead to avoiding intimacy altogether, which can cause relationship strain, decreased self-esteem, and feelings of isolation. Many women report that addressing vaginal dryness improves not only their physical comfort but also their emotional health and relationship satisfaction.

The good news is that with treatment, these complications can be prevented or reversed. Various safe and effective treatments are available, ranging from over-the-counter moisturizers and lubricants to prescription hormone therapies. Most women find significant relief with appropriate treatment, and many treatment options can be used long-term safely to maintain vaginal health.

Survival rate

Vulvovaginal dryness is not a life-threatening condition and does not affect survival rates. It is a quality-of-life issue rather than a disease that impacts life expectancy. Women with vaginal dryness have the same life expectancy as those without the condition.

Did you know?

  1. The vaginal pH can actually be tested with a simple paper strip, similar to litmus paper used in chemistry class, providing instant results during an examination.
  2. Despite affecting more than half of postmenopausal women, approximately 75% of women with vaginal dryness never receive a proper diagnosis because they don't discuss symptoms with their doctor.
  3. Vaginal tissues respond to estrogen levels so dramatically that their appearance can change noticeably within weeks of hormone level fluctuations, making visual examination a surprisingly reliable diagnostic tool.

Questions people often ask

This guide is here to help you understand the condition. It does not replace a conversation with your doctor, who knows your situation best.

Clinical trials for Vulvovaginal dryness

Recruiting trials first

See all 1 trials →
Quick filters

1 clinical trial in this condition

Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Nomegestrol Acetate
  • Sponsor:Aarhus University Hospital
See all 1 trials →filters applied: condition = Vulvovaginal dryness

Related conditions in the same therapeutic area

Back to all diseases
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).